

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | anatomical structure regression (GO:0060033) | 8.92420816 |
| 2 | natural killer cell activation involved in immune response (GO:0002323) | 8.57105397 |
| 3 | fructose metabolic process (GO:0006000) | 8.10768164 |
| 4 | digestive tract morphogenesis (GO:0048546) | 7.79258221 |
| 5 | cardiovascular system development (GO:0072358) | 7.54644921 |
| 6 | retina layer formation (GO:0010842) | 7.23637897 |
| 7 | regulation of helicase activity (GO:0051095) | 7.03036150 |
| 8 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 6.93713519 |
| 9 | iron coordination entity transport (GO:1901678) | 6.15457992 |
| 10 | positive regulation of hair cycle (GO:0042635) | 6.02552337 |
| 11 | positive regulation of hair follicle development (GO:0051798) | 6.02552337 |
| 12 | regulation of SMAD protein import into nucleus (GO:0060390) | 5.84518289 |
| 13 | positive regulation of osteoblast proliferation (GO:0033690) | 5.50076946 |
| 14 | pre-miRNA processing (GO:0031054) | 5.46515889 |
| 15 | sodium-independent organic anion transport (GO:0043252) | 5.24748286 |
| 16 | angiogenesis involved in wound healing (GO:0060055) | 4.97866181 |
| 17 | DNA topological change (GO:0006265) | 4.92252885 |
| 18 | cellular response to dsRNA (GO:0071359) | 4.84744028 |
| 19 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.82214691 |
| 20 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.79461962 |
| 21 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.74482977 |
| 22 | negative regulation of defense response to virus (GO:0050687) | 4.68451531 |
| 23 | proximal/distal pattern formation (GO:0009954) | 4.47450378 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 4.46825763 |
| 25 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.40486654 |
| 26 | ATP synthesis coupled proton transport (GO:0015986) | 4.40486654 |
| 27 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.35584878 |
| 28 | ovulation cycle (GO:0042698) | 4.34265565 |
| 29 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.31936209 |
| 30 | positive regulation of smoothened signaling pathway (GO:0045880) | 4.29018060 |
| 31 | mating behavior (GO:0007617) | 4.27676027 |
| 32 | pituitary gland development (GO:0021983) | 4.25945714 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12731956 |
| 34 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.96432565 |
| 35 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.94099489 |
| 36 | regulation of activation of Janus kinase activity (GO:0010533) | 3.93829386 |
| 37 | negative regulation of phagocytosis (GO:0050765) | 3.83935607 |
| 38 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 3.83460743 |
| 39 | negative regulation of cell size (GO:0045792) | 3.83364984 |
| 40 | magnesium ion transport (GO:0015693) | 3.77071519 |
| 41 | regulation of apoptotic cell clearance (GO:2000425) | 3.72504243 |
| 42 | ncRNA catabolic process (GO:0034661) | 3.64548810 |
| 43 | positive regulation of regulated secretory pathway (GO:1903307) | 3.62663468 |
| 44 | regulation of defense response to virus by host (GO:0050691) | 3.62496024 |
| 45 | positive regulation of gastrulation (GO:2000543) | 3.62439802 |
| 46 | regulation of hair follicle development (GO:0051797) | 3.62177438 |
| 47 | ovulation from ovarian follicle (GO:0001542) | 3.61542297 |
| 48 | DNA integration (GO:0015074) | 3.56825639 |
| 49 | cell-cell junction maintenance (GO:0045217) | 3.56780052 |
| 50 | phosphatidylethanolamine metabolic process (GO:0046337) | 3.55902346 |
| 51 | carbohydrate phosphorylation (GO:0046835) | 3.50653699 |
| 52 | glycoprotein catabolic process (GO:0006516) | 3.46408009 |
| 53 | pattern specification involved in kidney development (GO:0061004) | 3.43864037 |
| 54 | leukocyte degranulation (GO:0043299) | 3.42706431 |
| 55 | nucleoside diphosphate catabolic process (GO:0009134) | 3.32207898 |
| 56 | regulation of mesoderm development (GO:2000380) | 3.31072272 |
| 57 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 3.26031734 |
| 58 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.24672111 |
| 59 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.23867931 |
| 60 | sulfur amino acid catabolic process (GO:0000098) | 3.22898578 |
| 61 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.22151568 |
| 62 | melanosome transport (GO:0032402) | 3.19713556 |
| 63 | cell migration in hindbrain (GO:0021535) | 3.18026965 |
| 64 | lipoxygenase pathway (GO:0019372) | 3.17364019 |
| 65 | cell junction maintenance (GO:0034331) | 3.16741911 |
| 66 | peptidyl-lysine dimethylation (GO:0018027) | 3.15696208 |
| 67 | negative regulation of response to biotic stimulus (GO:0002832) | 3.12209414 |
| 68 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.10706256 |
| 69 | histone H3-K36 demethylation (GO:0070544) | 3.09943002 |
| 70 | establishment of melanosome localization (GO:0032401) | 3.08266968 |
| 71 | regulation of cilium movement (GO:0003352) | 3.05919310 |
| 72 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.05726842 |
| 73 | tolerance induction (GO:0002507) | 3.05590662 |
| 74 | pigment granule transport (GO:0051904) | 3.04151185 |
| 75 | melanocyte differentiation (GO:0030318) | 3.02150580 |
| 76 | platelet dense granule organization (GO:0060155) | 3.00862787 |
| 77 | regulation of gastrulation (GO:0010470) | 2.99720754 |
| 78 | negative regulation of B cell proliferation (GO:0030889) | 2.99431409 |
| 79 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.96546356 |
| 80 | dorsal/ventral pattern formation (GO:0009953) | 2.96192604 |
| 81 | filopodium assembly (GO:0046847) | 2.94978221 |
| 82 | positive regulation by host of viral transcription (GO:0043923) | 2.93912595 |
| 83 | establishment of pigment granule localization (GO:0051905) | 2.93878899 |
| 84 | nitric oxide mediated signal transduction (GO:0007263) | 2.93424082 |
| 85 | negative regulation of glial cell proliferation (GO:0060253) | 2.92245788 |
| 86 | embryonic heart tube development (GO:0035050) | 2.90378309 |
| 87 | response to exogenous dsRNA (GO:0043330) | 2.90332002 |
| 88 | positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862) | 2.89212529 |
| 89 | endoderm formation (GO:0001706) | 2.85908713 |
| 90 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.84860473 |
| 91 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.84533235 |
| 92 | positive regulation of vesicle fusion (GO:0031340) | 2.83820221 |
| 93 | histone H3-K9 methylation (GO:0051567) | 2.83725512 |
| 94 | positive regulation of neurological system process (GO:0031646) | 2.81722566 |
| 95 | regulation of regulated secretory pathway (GO:1903305) | 2.79611206 |
| 96 | natural killer cell activation (GO:0030101) | 2.77912184 |
| 97 | mRNA transcription (GO:0009299) | 2.72905964 |
| 98 | melanosome localization (GO:0032400) | 2.71886364 |
| 99 | cytokine production involved in immune response (GO:0002367) | 2.69090985 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 10.3917893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 6.99501393 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.29126457 |
| 3 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.97083933 |
| 4 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.92003233 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.64536988 |
| 6 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.63597731 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53819581 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41381675 |
| 9 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.40089472 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.39584567 |
| 11 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.36595358 |
| 12 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.14220406 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.13811496 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05730491 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.02276378 |
| 16 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.02276378 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.01524826 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.00124130 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.99844927 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.99351834 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.97764961 |
| 22 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.89995123 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77593166 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.74899441 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72389659 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67665433 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67450776 |
| 28 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.66483536 |
| 29 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66483536 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.66150186 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66147575 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62516165 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61189892 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58737764 |
| 35 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.57066046 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47445882 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.44875985 |
| 38 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.40951870 |
| 39 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.35631662 |
| 40 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34559580 |
| 41 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.34386602 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33660950 |
| 43 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.30605808 |
| 44 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30250962 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.30229751 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29116655 |
| 47 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.29034119 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.26871374 |
| 49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25948684 |
| 50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25794370 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25384810 |
| 52 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24534873 |
| 53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.17801089 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16038952 |
| 55 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.14459407 |
| 56 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14314878 |
| 57 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12875401 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12364393 |
| 59 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08204984 |
| 60 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07128457 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06419445 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06298692 |
| 63 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06298692 |
| 64 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06298692 |
| 65 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05875464 |
| 66 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05306197 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03419963 |
| 68 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02435913 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02380971 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01959609 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.00549981 |
| 72 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99946490 |
| 73 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99913025 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.93447751 |
| 75 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.92879274 |
| 76 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92727161 |
| 77 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.92086649 |
| 78 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91890026 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.90421805 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90253786 |
| 81 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.87484505 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87368745 |
| 83 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86429865 |
| 84 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85947977 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.84689628 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84655831 |
| 87 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.84518933 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83411170 |
| 89 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.82750104 |
| 90 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82618486 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.82588395 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82266582 |
| 93 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81438688 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81279212 |
| 95 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81278226 |
| 96 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81239776 |
| 97 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80733505 |
| 98 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80484002 |
| 99 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.79632446 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78639882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 8.88859317 |
| 2 | MP0005084_abnormal_gallbladder_morpholo | 8.32934667 |
| 3 | MP0003252_abnormal_bile_duct | 5.12273214 |
| 4 | MP0002928_abnormal_bile_duct | 4.94097590 |
| 5 | MP0004133_heterotaxia | 4.19662094 |
| 6 | MP0000462_abnormal_digestive_system | 4.15591922 |
| 7 | MP0008995_early_reproductive_senescence | 3.33593552 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.82133876 |
| 9 | MP0003315_abnormal_perineum_morphology | 2.79937465 |
| 10 | MP0005408_hypopigmentation | 2.72900128 |
| 11 | MP0001919_abnormal_reproductive_system | 2.55975542 |
| 12 | MP0000631_abnormal_neuroendocrine_gland | 2.52363390 |
| 13 | MP0005220_abnormal_exocrine_pancreas | 2.23028668 |
| 14 | MP0001270_distended_abdomen | 2.09657591 |
| 15 | MP0005389_reproductive_system_phenotype | 1.99753267 |
| 16 | MP0002095_abnormal_skin_pigmentation | 1.83061040 |
| 17 | MP0005187_abnormal_penis_morphology | 1.75991080 |
| 18 | MP0005381_digestive/alimentary_phenotyp | 1.67637361 |
| 19 | MP0003283_abnormal_digestive_organ | 1.63296876 |
| 20 | MP0000371_diluted_coat_color | 1.62664228 |
| 21 | MP0008569_lethality_at_weaning | 1.51372762 |
| 22 | MP0003119_abnormal_digestive_system | 1.43727618 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.39794572 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.24954658 |
| 25 | MP0008932_abnormal_embryonic_tissue | 1.24826831 |
| 26 | MP0002277_abnormal_respiratory_mucosa | 1.18993553 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.18472964 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.12341331 |
| 29 | MP0002160_abnormal_reproductive_system | 1.12175459 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.10771412 |
| 31 | MP0003866_abnormal_defecation | 1.07760583 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.06997437 |
| 33 | MP0003646_muscle_fatigue | 1.05592662 |
| 34 | MP0008260_abnormal_autophagy | 1.02497999 |
| 35 | MP0002136_abnormal_kidney_physiology | 0.90377201 |
| 36 | MP0009785_altered_susceptibility_to | 0.83838604 |
| 37 | MP0005083_abnormal_biliary_tract | 0.81408781 |
| 38 | MP0003195_calcinosis | 0.78122007 |
| 39 | MP0002653_abnormal_ependyma_morphology | 0.76411038 |
| 40 | MP0005464_abnormal_platelet_physiology | 0.75102769 |
| 41 | MP0005671_abnormal_response_to | 0.73342729 |
| 42 | MP0003936_abnormal_reproductive_system | 0.72604084 |
| 43 | MP0000013_abnormal_adipose_tissue | 0.70733218 |
| 44 | MP0001944_abnormal_pancreas_morphology | 0.70288629 |
| 45 | MP0009703_decreased_birth_body | 0.68850856 |
| 46 | MP0003879_abnormal_hair_cell | 0.67469105 |
| 47 | MP0008872_abnormal_physiological_respon | 0.67129924 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 0.66970388 |
| 49 | MP0002127_abnormal_cardiovascular_syste | 0.66802676 |
| 50 | MP0001663_abnormal_digestive_system | 0.65656618 |
| 51 | MP0004043_abnormal_pH_regulation | 0.64571923 |
| 52 | MP0001756_abnormal_urination | 0.62936052 |
| 53 | MP0004858_abnormal_nervous_system | 0.61313523 |
| 54 | MP0001881_abnormal_mammary_gland | 0.58408942 |
| 55 | MP0008789_abnormal_olfactory_epithelium | 0.57756432 |
| 56 | MP0000049_abnormal_middle_ear | 0.56243652 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 0.56092002 |
| 58 | MP0002166_altered_tumor_susceptibility | 0.55129638 |
| 59 | MP0000647_abnormal_sebaceous_gland | 0.54517850 |
| 60 | MP0002075_abnormal_coat/hair_pigmentati | 0.54488080 |
| 61 | MP0004883_abnormal_blood_vessel | 0.53316037 |
| 62 | MP0003828_pulmonary_edema | 0.52245086 |
| 63 | MP0003942_abnormal_urinary_system | 0.52199286 |
| 64 | MP0003786_premature_aging | 0.51913472 |
| 65 | MP0002163_abnormal_gland_morphology | 0.51767624 |
| 66 | MP0001502_abnormal_circadian_rhythm | 0.51585869 |
| 67 | MP0002557_abnormal_social/conspecific_i | 0.51334158 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 0.51239985 |
| 69 | MP0005410_abnormal_fertilization | 0.51024842 |
| 70 | MP0002102_abnormal_ear_morphology | 0.50682216 |
| 71 | MP0005387_immune_system_phenotype | 0.49905571 |
| 72 | MP0001790_abnormal_immune_system | 0.49905571 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.48977287 |
| 74 | MP0009745_abnormal_behavioral_response | 0.48592768 |
| 75 | MP0000955_abnormal_spinal_cord | 0.47371330 |
| 76 | MP0002108_abnormal_muscle_morphology | 0.46542273 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.45264989 |
| 78 | MP0002067_abnormal_sensory_capabilities | 0.44745651 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.44273861 |
| 80 | MP0002234_abnormal_pharynx_morphology | 0.42939061 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.42672777 |
| 82 | MP0002184_abnormal_innervation | 0.42573584 |
| 83 | MP0001873_stomach_inflammation | 0.42175935 |
| 84 | MP0002006_tumorigenesis | 0.42064350 |
| 85 | MP0005025_abnormal_response_to | 0.41937559 |
| 86 | MP0002572_abnormal_emotion/affect_behav | 0.40333841 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.40135620 |
| 88 | MP0000467_abnormal_esophagus_morphology | 0.38936282 |
| 89 | MP0002135_abnormal_kidney_morphology | 0.37756161 |
| 90 | MP0002736_abnormal_nociception_after | 0.37561995 |
| 91 | MP0000627_abnormal_mammary_gland | 0.37264532 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.36829894 |
| 93 | MP0003984_embryonic_growth_retardation | 0.36747312 |
| 94 | MP0000490_abnormal_crypts_of | 0.36352919 |
| 95 | MP0004084_abnormal_cardiac_muscle | 0.35881067 |
| 96 | MP0000653_abnormal_sex_gland | 0.35250557 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.35188352 |
| 98 | MP0008775_abnormal_heart_ventricle | 0.34976210 |
| 99 | MP0003938_abnormal_ear_development | 0.34566224 |
| 100 | MP0010329_abnormal_lipoprotein_level | 0.34524730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neoplasm of the tracheobronchial system (HP:0100552) | 9.80972870 |
| 2 | Tetany (HP:0001281) | 6.44409099 |
| 3 | Hypomagnesemia (HP:0002917) | 6.29323177 |
| 4 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.68015241 |
| 5 | Abnormality of magnesium homeostasis (HP:0004921) | 5.12172405 |
| 6 | Abnormal drinking behavior (HP:0030082) | 4.98332941 |
| 7 | Polydipsia (HP:0001959) | 4.98332941 |
| 8 | Ependymoma (HP:0002888) | 4.93948937 |
| 9 | Neoplasm of the heart (HP:0100544) | 4.87925160 |
| 10 | Pulmonary infiltrates (HP:0002113) | 4.47950874 |
| 11 | Generalized hypopigmentation of hair (HP:0011358) | 4.27969405 |
| 12 | Neoplasm of the lung (HP:0100526) | 4.05477714 |
| 13 | Lymphangioma (HP:0100764) | 3.95107018 |
| 14 | Synostosis involving the elbow (HP:0003938) | 3.72762920 |
| 15 | Humeroradial synostosis (HP:0003041) | 3.72762920 |
| 16 | Neoplasm of the respiratory system (HP:0100606) | 3.58427561 |
| 17 | Polyuria (HP:0000103) | 3.57538252 |
| 18 | Abnormality of purine metabolism (HP:0004352) | 3.49232990 |
| 19 | Abnormality of the astrocytes (HP:0100707) | 3.44065715 |
| 20 | Astrocytoma (HP:0009592) | 3.44065715 |
| 21 | Bronchomalacia (HP:0002780) | 3.38011923 |
| 22 | Hemiplegia (HP:0002301) | 3.18840291 |
| 23 | Renal tubular acidosis (HP:0001947) | 3.17413463 |
| 24 | Tracheomalacia (HP:0002779) | 3.17099437 |
| 25 | Increased purine levels (HP:0004368) | 3.14844697 |
| 26 | Hyperuricemia (HP:0002149) | 3.14844697 |
| 27 | Progressive neurologic deterioration (HP:0002344) | 3.12719077 |
| 28 | Abnormal urine output (HP:0012590) | 3.06714022 |
| 29 | Congenital, generalized hypertrichosis (HP:0004540) | 2.98713416 |
| 30 | Fibular aplasia (HP:0002990) | 2.97873654 |
| 31 | Ocular albinism (HP:0001107) | 2.87962242 |
| 32 | Hypothermia (HP:0002045) | 2.76676495 |
| 33 | Glioma (HP:0009733) | 2.73742431 |
| 34 | Abnormality of the axillary hair (HP:0100134) | 2.72661105 |
| 35 | Abnormality of secondary sexual hair (HP:0009888) | 2.72661105 |
| 36 | Premature graying of hair (HP:0002216) | 2.72198782 |
| 37 | Abnormality of the vertebral endplates (HP:0005106) | 2.64017447 |
| 38 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.60435487 |
| 39 | Persistence of primary teeth (HP:0006335) | 2.59094971 |
| 40 | Abnormality of renal excretion (HP:0011036) | 2.57648109 |
| 41 | Iris hypopigmentation (HP:0007730) | 2.56315660 |
| 42 | Thyroid-stimulating hormone excess (HP:0002925) | 2.54052744 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.45618969 |
| 44 | Split foot (HP:0001839) | 2.43072231 |
| 45 | Agitation (HP:0000713) | 2.39076861 |
| 46 | Increased serum ferritin (HP:0003281) | 2.38092512 |
| 47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.37354553 |
| 48 | Infantile muscular hypotonia (HP:0008947) | 2.33703800 |
| 49 | Abnormal sex determination (HP:0012244) | 2.32088187 |
| 50 | Sex reversal (HP:0012245) | 2.32088187 |
| 51 | Conical tooth (HP:0000698) | 2.29929701 |
| 52 | Hamartoma of the eye (HP:0010568) | 2.28658443 |
| 53 | Skin nodule (HP:0200036) | 2.18413034 |
| 54 | Enlarged epiphyses (HP:0010580) | 2.17199485 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.12375316 |
| 56 | Hemangiomatosis (HP:0007461) | 2.09363338 |
| 57 | Flattened epiphyses (HP:0003071) | 2.08596361 |
| 58 | Visceral angiomatosis (HP:0100761) | 2.06431940 |
| 59 | Renal tubular dysfunction (HP:0000124) | 2.03371693 |
| 60 | Spinal muscular atrophy (HP:0007269) | 2.02785101 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.02426551 |
| 62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01066738 |
| 63 | Alveolar cell carcinoma (HP:0006519) | 10.7298752 |
| 64 | Oligodactyly (hands) (HP:0001180) | 1.97841105 |
| 65 | Meningitis (HP:0001287) | 1.95756045 |
| 66 | Mitral stenosis (HP:0001718) | 1.91968581 |
| 67 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.91220524 |
| 68 | Hypopigmentation of the fundus (HP:0007894) | 1.88753134 |
| 69 | Apathy (HP:0000741) | 1.87586551 |
| 70 | Dialeptic seizures (HP:0011146) | 1.87408547 |
| 71 | Neoplasm of striated muscle (HP:0009728) | 1.86642450 |
| 72 | Broad ribs (HP:0000885) | 1.85166081 |
| 73 | Natal tooth (HP:0000695) | 1.84950758 |
| 74 | Microglossia (HP:0000171) | 1.84878330 |
| 75 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.84796105 |
| 76 | Polygenic inheritance (HP:0010982) | 1.83784721 |
| 77 | Molar tooth sign on MRI (HP:0002419) | 1.82068472 |
| 78 | Abnormality of midbrain morphology (HP:0002418) | 1.82068472 |
| 79 | Hemiparesis (HP:0001269) | 1.80131263 |
| 80 | Stridor (HP:0010307) | 1.79465922 |
| 81 | Death in childhood (HP:0003819) | 1.76773577 |
| 82 | Hemoptysis (HP:0002105) | 1.75761900 |
| 83 | Hematuria (HP:0000790) | 1.75592786 |
| 84 | Stomach cancer (HP:0012126) | 1.73343393 |
| 85 | Atelectasis (HP:0100750) | 1.73117817 |
| 86 | Hypercalciuria (HP:0002150) | 1.69925167 |
| 87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.69081529 |
| 88 | Abnormality of the anterior horn cell (HP:0006802) | 1.68940365 |
| 89 | Degeneration of anterior horn cells (HP:0002398) | 1.68940365 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.68040603 |
| 91 | Weak cry (HP:0001612) | 1.67880581 |
| 92 | Diaphragmatic weakness (HP:0009113) | 1.67431853 |
| 93 | Diminished motivation (HP:0000745) | 1.67045732 |
| 94 | Gingivitis (HP:0000230) | 1.66022611 |
| 95 | Abnormality of T cells (HP:0002843) | 1.64404861 |
| 96 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64150175 |
| 97 | Macroglossia (HP:0000158) | 1.63723577 |
| 98 | Anal stenosis (HP:0002025) | 1.63265087 |
| 99 | Rectal fistula (HP:0100590) | 1.62877207 |
| 100 | Rectovaginal fistula (HP:0000143) | 1.62877207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAF1 | 8.27761932 |
| 2 | STK38L | 5.38725402 |
| 3 | STK24 | 4.74932223 |
| 4 | PRKCI | 4.60137156 |
| 5 | MAP3K5 | 3.29787595 |
| 6 | BLK | 2.64853705 |
| 7 | CAMK1D | 2.52562501 |
| 8 | TLK1 | 2.50145179 |
| 9 | MAPK15 | 2.40337122 |
| 10 | TAOK3 | 2.11209652 |
| 11 | MATK | 1.99071972 |
| 12 | JAK3 | 1.87929034 |
| 13 | TEC | 1.78974395 |
| 14 | ITK | 1.78540849 |
| 15 | CAMK1G | 1.74281460 |
| 16 | TRIB3 | 1.57684455 |
| 17 | INSRR | 1.52978155 |
| 18 | CAMK1 | 1.47914537 |
| 19 | CAMK4 | 1.42649092 |
| 20 | PTK6 | 1.32522728 |
| 21 | IKBKB | 1.18672739 |
| 22 | ERBB2 | 1.16721156 |
| 23 | ADRBK2 | 1.08712326 |
| 24 | STK3 | 1.06027272 |
| 25 | PLK4 | 1.00963834 |
| 26 | MAP4K2 | 0.94151946 |
| 27 | SYK | 0.91314335 |
| 28 | ZAK | 0.91031282 |
| 29 | TIE1 | 0.89664414 |
| 30 | WNK4 | 0.86822591 |
| 31 | TXK | 0.86517119 |
| 32 | BMPR1B | 0.82807024 |
| 33 | MAP3K14 | 0.82421202 |
| 34 | GRK1 | 0.79832851 |
| 35 | STK16 | 0.76141351 |
| 36 | IKBKE | 0.74936581 |
| 37 | ERBB4 | 0.73527623 |
| 38 | STK39 | 0.72044963 |
| 39 | AKT3 | 0.71881833 |
| 40 | MKNK2 | 0.68400122 |
| 41 | BTK | 0.66740322 |
| 42 | VRK1 | 0.66567804 |
| 43 | MAP3K4 | 0.66501926 |
| 44 | KIT | 0.64692613 |
| 45 | OXSR1 | 0.59756946 |
| 46 | OBSCN | 0.59480401 |
| 47 | CSF1R | 0.58681456 |
| 48 | CDK3 | 0.56407951 |
| 49 | FRK | 0.56377195 |
| 50 | WNK3 | 0.56372728 |
| 51 | CSK | 0.56231982 |
| 52 | NTRK2 | 0.55920536 |
| 53 | NME1 | 0.54712790 |
| 54 | EIF2AK2 | 0.54468874 |
| 55 | MAP2K7 | 0.54031445 |
| 56 | PKN1 | 0.53770604 |
| 57 | PHKG1 | 0.51622018 |
| 58 | PHKG2 | 0.51622018 |
| 59 | PINK1 | 0.49476909 |
| 60 | CAMK2A | 0.47593117 |
| 61 | TSSK6 | 0.46314019 |
| 62 | RPS6KA6 | 0.43900797 |
| 63 | CSNK1A1 | 0.43399234 |
| 64 | BCKDK | 0.42823947 |
| 65 | PAK3 | 0.40679785 |
| 66 | NTRK1 | 0.40649804 |
| 67 | CHUK | 0.40319759 |
| 68 | PRKCZ | 0.39428715 |
| 69 | RPS6KC1 | 0.38938494 |
| 70 | RPS6KL1 | 0.38938494 |
| 71 | EPHA2 | 0.38682944 |
| 72 | PRKAA1 | 0.37793327 |
| 73 | LYN | 0.37368845 |
| 74 | PRKCG | 0.36119844 |
| 75 | MKNK1 | 0.35764624 |
| 76 | MET | 0.35456208 |
| 77 | RPS6KA2 | 0.34139316 |
| 78 | MAPKAPK5 | 0.32508129 |
| 79 | IGF1R | 0.32291830 |
| 80 | ATR | 0.32025151 |
| 81 | MUSK | 0.31091675 |
| 82 | TRIM28 | 0.31079607 |
| 83 | KDR | 0.30718974 |
| 84 | TBK1 | 0.30438503 |
| 85 | ACVR1B | 0.30173235 |
| 86 | CSNK2A1 | 0.30158447 |
| 87 | AKT1 | 0.28826033 |
| 88 | IRAK4 | 0.28609038 |
| 89 | PRKACA | 0.28253805 |
| 90 | TGFBR1 | 0.24921840 |
| 91 | LCK | 0.24757630 |
| 92 | INSR | 0.24290878 |
| 93 | CDK7 | 0.23646183 |
| 94 | PRKCQ | 0.23568362 |
| 95 | MAPK7 | 0.23543026 |
| 96 | PRKAA2 | 0.23374106 |
| 97 | FGFR2 | 0.21563420 |
| 98 | ATM | 0.21460090 |
| 99 | PRKG1 | 0.20961082 |
| 100 | PRKCD | 0.18963192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.96945472 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.51512103 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.47756602 |
| 4 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 3.31200071 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 3.25250659 |
| 6 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.78732676 |
| 7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.74162733 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.60692046 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 2.26917008 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.06962319 |
| 11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.05109612 |
| 12 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.97523311 |
| 13 | Asthma_Homo sapiens_hsa05310 | 1.95838429 |
| 14 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.87084624 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.86349198 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84702140 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.80938825 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70828718 |
| 19 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58075349 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53092097 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.51160818 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.49722158 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.48240764 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46085502 |
| 25 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.42067508 |
| 26 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.26172179 |
| 27 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24405417 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.22475692 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21656649 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21050461 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20760080 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19726444 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13415571 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12488293 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10472344 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08230137 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.07740927 |
| 38 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05540867 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03963093 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01354064 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.99785086 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99150967 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98631879 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 0.97460848 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94730290 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91866751 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.91520546 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87600063 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87541804 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84649196 |
| 51 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82883013 |
| 52 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81685409 |
| 53 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81275865 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81222804 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.78341740 |
| 56 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.78055192 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77667735 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77105846 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.76737204 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73996595 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.70906413 |
| 62 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69100734 |
| 63 | Nicotine addiction_Homo sapiens_hsa05033 | 0.69050425 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66673005 |
| 65 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62961696 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62354517 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56878906 |
| 68 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.56153737 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55730271 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55092890 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51901249 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51242320 |
| 73 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50130244 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49986266 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.49299118 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47480847 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47344682 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.47164004 |
| 79 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45474778 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44206714 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43188305 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41782113 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41380379 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40539535 |
| 85 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39041647 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38300206 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37931321 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37344698 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36425891 |
| 90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36093516 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.36040354 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.31840739 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31555794 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28775452 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26272215 |
| 96 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.24646288 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24325759 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23937356 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.23509396 |
| 100 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23396115 |

